|
|
Volumn 66, Issue 1, 2011, Pages 2-4
|
|
Contraceptive Vaccines: Success, Status, and Future Perspective
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CHORIONIC GONADOTROPIN;
CONTRACEPTIVE VACCINE;
EPITOPE;
EQUITY;
FOLLITROPIN;
GONACON;
GONADORELIN;
IMPROVAC;
LUTEINIZING HORMONE;
ORAL CONTRACEPTIVE AGENT;
REPROBLOC;
SPAYVAC;
SPERM ANTIBODY;
SPERM ANTIGEN;
SPERMICIDAL AGENT;
UNCLASSIFIED DRUG;
ZONA PELLUCIDA VACCINE;
ANTIBODY RESPONSE;
BARRIER CONTRACEPTION;
DEVELOPING COUNTRY;
DOMESTIC ANIMAL;
DRUG COST;
DRUG SAFETY;
EDITORIAL;
EMERGENCY CONTRACEPTION;
ENDOMETRIOSIS;
FEMALE STERILIZATION;
GAMETE;
HUMAN;
IMMUNOCONTRACEPTION;
INDUCED ABORTION;
INFERTILITY;
INTRAUTERINE CONTRACEPTIVE DEVICE;
MALE STERILIZATION;
OVARY INFLAMMATION;
OVARY POLYCYSTIC DISEASE;
PRECOCIOUS PUBERTY;
PREGNANCY;
PRIORITY JOURNAL;
UNPLANNED PREGNANCY;
UTERUS MYOMA;
WILDLIFE;
ZONA PELLUCIDA;
ANIMALS;
ANTIGENS;
CATTLE;
CHORIONIC GONADOTROPIN;
CONTRACEPTION, IMMUNOLOGIC;
CONTRACEPTIVE AGENTS;
EGG PROTEINS;
FAMILY PLANNING SERVICES;
FEMALE;
FERTILITY;
FOLLICLE STIMULATING HORMONE;
GONADOTROPIN-RELEASING HORMONE;
HUMANS;
IMMUNIZATION;
LUTEINIZING HORMONE;
MALE;
MEMBRANE GLYCOPROTEINS;
OOCYTES;
RECEPTORS, CELL SURFACE;
SPERMATOZOA;
VACCINES, CONTRACEPTIVE;
ZONA PELLUCIDA;
|
|
EID: 79958155950
PISSN: 10467408
EISSN: 16000897
Source Type: Journal
DOI: 10.1111/j.1600-0897.2011.00999.x Document Type: Editorial |
|
Times cited : (14)
|
|
References (8)
|
